Literature DB >> 26344942

THE metabolic syndrome and accurate cardiovascular risk prediction in persons with type 2 diabetes mellitus.

A Ipadeola1, J O Adeleye2.   

Abstract

BACKGROUND: Persons with type 2 DM have a cardiovascular risk 2-4 times that of the normal population. Co-occurrence of metabolic syndrome (MS) with type 2 DM is associated with an increased risk of development of cardiovascular disease. The aim of this study was to determine the prevalence of the MS in patients with type 2 diabetes mellitus and to compare absolute cardiovascular risk in type 2 DM Patients with MS with those without MS.
METHODS: Anthropometric measurements and Blood Pressure of 340 eligible patients with type 2 DM recruited into the study were taken. Participants' FPG, FLP and glycated haemoglobin were also estimated. Cardiovascular risk score was calculated using the United Kingdom Prospective Diabetes Study (UKPDS) risk engine. Diagnosis of the MS was the International Diabetes Federation Criteria (IDF).
RESULTS: Over 66% participants had MS. The absolute cardiovascular risk score was found to be similar in persons with type 2 DM whether they fulfilled the criteria for diagnosis metabolic syndrome or not.
CONCLUSION: The absolute cardiovascular risk score was similar in type 2 DM patients with or without the metabolic syndrome.
Copyright © 2015 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calculated absolute cardiovascular risk; Metabolic syndrome; Type 2 diabetes mellitus; UKPDS risk engine

Mesh:

Substances:

Year:  2015        PMID: 26344942     DOI: 10.1016/j.dsx.2015.08.011

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  6 in total

1.  Prevalence of metabolic syndrome, discrete or comorbid diabetes and hypertension in sub-Saharan Africa among people living with HIV versus HIV-negative populations: a systematic review and meta-analysis protocol.

Authors:  Olamide O Todowede; Benn Sartorius
Journal:  BMJ Open       Date:  2017-07-09       Impact factor: 2.692

2.  Leptin is an independent marker of metabolic syndrome in elderly adults with type 2 diabetes.

Authors:  Pei-Wei Tseng; Du-An Wu; Jia-Sian Hou; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Apr-Jun

3.  Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region, Ghana.

Authors:  Timothy Agandah Abagre; Delia Akosua Bandoh; Adolphina Addoley Addo-Lartey
Journal:  BMC Cardiovasc Disord       Date:  2022-08-10       Impact factor: 2.174

4.  The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia.

Authors:  Belete Biadgo; Tadele Melak; Sintayehu Ambachew; Habtamu Wondifraw Baynes; Miteku Andualem Limenih; Kefyalew Negerie Jaleta; Belaynesh Tachebele; Mulugeta Melku; Molla Abebe
Journal:  Ethiop J Health Sci       Date:  2018-09

5.  Predicting the risk of stroke among patients with type 2 diabetes: a systematic review and meta-analysis of C-statistics.

Authors:  Mohammad Ziaul Islam Chowdhury; Fahmida Yeasmin; Doreen M Rabi; Paul E Ronksley; Tanvir C Turin
Journal:  BMJ Open       Date:  2019-08-30       Impact factor: 2.692

6.  Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.

Authors:  João Pedro Ferreira; Subodh Verma; David Fitchett; Anne Pernille Ofstad; Sabine Lauer; Isabella Zwiener; Jyothis George; Christoph Wanner; Bernard Zinman; Silvio E Inzucchi
Journal:  Cardiovasc Diabetol       Date:  2020-11-26       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.